BuzzSparks.org

BaroFold


BaroFold is a privately held biopharmaceutical company focused on the development of commercially attractive protein therapeutics for immunology indications. The company’s goal is to discover, develop and commercialize protein biologics, some of...

Founded in 2003
Homepage:
Total money raised: $17.7M

80045 12635 E. Montview Blvd
Suite 217

Aurora
Aurora
USA CO

Phone: 303-926-0337

Updated on Jun 19, 2013
BaroFold at CrunchBase
Kyle Lefkoff Board Chairman
Matthew Brewer Chief Executive Officer and President
Julie L. Bernard Chief Intellectual Property Counsel
Past
Lyndal Hesterberg President / CEO
Jeffrey Clearland Vice President, Therapeutic Development

February, 2013

BaroFold raised $1.7M in a Series D round

SEC    sec.gov

August, 2012

BaroFold raised $1.5M in seed round

SEC    sec.gov

May, 2007

BaroFold raised $12M in a Series A round from HBM BioVentures, Boulder Ventures, and The Peierls Foundation

BaroFold pulls in $12M for protein-refolding technology    venturebeat.com

March, 2006

BaroFold raised $2.5M in unattributed round from Boulder Ventures and The Peierls Foundation

2003

BaroFold was founded in 2003